摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one

中文名称
——
中文别名
——
英文名称
(E)-4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one
英文别名
——
(E)-4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one化学式
CAS
——
化学式
C14H16N8O
mdl
——
分子量
312.334
InChiKey
MVLHTHXONXMDNX-ISLYRVAYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.79
  • 重原子数:
    23.0
  • 可旋转键数:
    3.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    132.37
  • 氢给体数:
    3.0
  • 氢受体数:
    8.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (E)-4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one丙烯腈吡啶 作用下, 以 为溶剂, 反应 4.0h, 以78%的产率得到(E)-3-{3,5-diamino-4-[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)diazenyl]-1H-pyrazol-1-yl}propanenitrile
    参考文献:
    名称:
    衍生自4取代的安替比林的一些新吡唑基,异恶唑基,嘧啶基,吡哒嗪基和吡咯并哒嗪基的衍生物,结构和生物学研究
    摘要:
    (1,5-二甲基-3-氧代-2-苯基-2,3-二氢-1 H-吡唑-4-基)羰基肼基二氰化物被用作合成新型吡唑,异恶唑,嘧啶的关键中间体和哒嗪衍生物。通过元素分析和光谱数据(IR,1 H-NMR,13 C-NMR和质谱)对新合成的化合物进行了表征。测试了这些化合物对革兰氏阳性菌(金黄色葡萄球菌和枯草芽孢杆菌)和革兰氏阴性菌(铜绿假单胞菌和大肠杆菌)的体外抗菌活性。)。使用扩散琼脂技术针对两种真菌Fabtrytis fabae和Fusarium oxysporum的菌株测试了所研究的化合物。生物学结果清楚地表明,大多数合成的化合物显示出对所用微生物的中等至中等活性。
    DOI:
    10.1002/jhet.2707
  • 作为产物:
    描述:
    参考文献:
    名称:
    4-Arylazo-3,5-diamino-1H-pyrazole CDK Inhibitors:  SAR Study, Crystal Structure in Complex with CDK2, Selectivity, and Cellular Effects
    摘要:
    In a routine screening of our small-molecule compound collection we recently identified 4-arylazo-3,5-diamino-1H-pyrazoles as a novel group of ATP antagonists with moderate potency against CDK2-cyclin E. A preliminary SAR study based on 35 analogues suggests ways in which the pharmacophore could be further optimized, for example, via substitutions in the 4-aryl ring. Enzyme kinetics studies with the lead compound and X-ray crystallography of an inhibitor-CDK2 complex demonstrated that its mode of inhibition is competitive. Functional kinase assays confirmed the selectivity toward CDKs, with a preference for CDK9cyclin T1. The most potent inhibitor, 4-[(3,5-diamino-1H-pyrazol-4-yl) diazenyl] phenol 31b (CAN508), reduced the frequency of S-phase cells of the cancer cell line HT-29 in antiproliferation assays. Further observed cellular effects included decreased phosphorylation of the retinoblastoma protein and the C-terminal domain of RNA polymerase II, inhibition of mRNA synthesis, and induction of the tumor suppressor protein p53, all of which are consistent with inhibition of CDK9.
    DOI:
    10.1021/jm0605740
点击查看最新优质反应信息

文献信息

  • AZO DERIVATIVES CONTAINING A PYRAZOLINONE UNIT FOR DYEING KERATIN FIBRES
    申请人:Fadli Aziz
    公开号:US20100269269A1
    公开(公告)日:2010-10-28
    The subject of the present invention is azo derivatives containing a pyrazolinone unit having the following formula (I), their mesomeric forms, their addition salts with an acid and their solvates and their use for dyeing keratin fibers. The subject of the invention is also a composition for dying keratin fibers comprising at least one azo derivative containing a pyrazolinone unit of formula (I) as direct dye, and the method for dyeing keratin fibers using this composition. The present invention makes it possible in particular to obtain chromatic colours that are resistant to the various attacks to which the hair may be subjected, in particular to shampoos and to light.
    本发明的主题是含有以下式(I)的吡唑啉酮单元的偶氮衍生物,它们的共振式形式,它们与酸的加合盐以及它们的溶剂化物,以及它们用于染色角蛋白纤维的用途。本发明的主题还包括一种用于染色角蛋白纤维的组合物,其中至少包括一种含有式(I)的吡唑啉酮单元的偶氮衍生物作为直接染料,以及使用该组合物染色角蛋白纤维的方法。本发明特别能够获得对头发可能遭受的各种攻击,特别是洗发水和光线,具有耐久性的色彩。
  • US8034124B2
    申请人:——
    公开号:US8034124B2
    公开(公告)日:2011-10-11
  • 4-Arylazo-3,5-diamino-1<i>H</i>-pyrazole CDK Inhibitors:  SAR Study, Crystal Structure in Complex with CDK2, Selectivity, and Cellular Effects
    作者:Vladimír Kryštof、Petr Cankař、Iveta Fryšová、Jan Slouka、George Kontopidis、Petr Džubák、Marián Hajdúch、Josef Srovnal、Walter F. de Azevedo、Martin Orság、Martina Paprskářová、Jakub Rolčík、Aleš Látr、Peter M. Fischer、Miroslav Strnad
    DOI:10.1021/jm0605740
    日期:2006.11.1
    In a routine screening of our small-molecule compound collection we recently identified 4-arylazo-3,5-diamino-1H-pyrazoles as a novel group of ATP antagonists with moderate potency against CDK2-cyclin E. A preliminary SAR study based on 35 analogues suggests ways in which the pharmacophore could be further optimized, for example, via substitutions in the 4-aryl ring. Enzyme kinetics studies with the lead compound and X-ray crystallography of an inhibitor-CDK2 complex demonstrated that its mode of inhibition is competitive. Functional kinase assays confirmed the selectivity toward CDKs, with a preference for CDK9cyclin T1. The most potent inhibitor, 4-[(3,5-diamino-1H-pyrazol-4-yl) diazenyl] phenol 31b (CAN508), reduced the frequency of S-phase cells of the cancer cell line HT-29 in antiproliferation assays. Further observed cellular effects included decreased phosphorylation of the retinoblastoma protein and the C-terminal domain of RNA polymerase II, inhibition of mRNA synthesis, and induction of the tumor suppressor protein p53, all of which are consistent with inhibition of CDK9.
  • Derivational, Structural, and Biological Studies of Some New Pyrazolyl, Isoxazolyl, Pyrimidinyl, Pyridazinyl, and Pyridopyridazinyl from 4-Substituted Antipyrine
    作者:Ahmed A. Fadda、Ramy Rabie、Samir Bondock、Hassan A. Etman
    DOI:10.1002/jhet.2707
    日期:2017.3
    5‐Dimethyl‐3‐oxo‐2‐phenyl‐2,3‐dihydro‐1H‐pyrazol‐4‐yl)carbono‐hydrazonoyl dicyanide was used as a key intermediate for the synthesis of novel pyrazole, isoxazole, pyrimidine, and pyridazine derivatives. The newly synthesized compounds were characterized by elemental analyses and spectral data (IR, 1H‐NMR, 13C‐NMR, and mass spectra). The compounds were tested for their in vitro antibacterial activity against
    (1,5-二甲基-3-氧代-2-苯基-2,3-二氢-1 H-吡唑-4-基)羰基肼基二氰化物被用作合成新型吡唑,异恶唑,嘧啶的关键中间体和哒嗪衍生物。通过元素分析和光谱数据(IR,1 H-NMR,13 C-NMR和质谱)对新合成的化合物进行了表征。测试了这些化合物对革兰氏阳性菌(金黄色葡萄球菌和枯草芽孢杆菌)和革兰氏阴性菌(铜绿假单胞菌和大肠杆菌)的体外抗菌活性。)。使用扩散琼脂技术针对两种真菌Fabtrytis fabae和Fusarium oxysporum的菌株测试了所研究的化合物。生物学结果清楚地表明,大多数合成的化合物显示出对所用微生物的中等至中等活性。
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺